These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15375799)

  • 1. Effect of pioglitazone on carotid intima-media thickness and arterial stiffness in type 2 diabetic nephropathy patients.
    Nakamura T; Matsuda T; Kawagoe Y; Ogawa H; Takahashi Y; Sekizuka K; Koide H
    Metabolism; 2004 Oct; 53(10):1382-6. PubMed ID: 15375799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of pioglitazone, glibenclamide, and voglibose on urinary endothelin-1 and albumin excretion in diabetes patients.
    Nakamura T; Ushiyama C; Shimada N; Hayashi K; Ebihara I; Koide H
    J Diabetes Complications; 2000; 14(5):250-4. PubMed ID: 11113686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria.
    Nakamura T; Sugaya T; Kawagoe Y; Ueda Y; Koide H
    Diabetes Metab Res Rev; 2006; 22(5):385-9. PubMed ID: 16506273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes.
    Koshiyama H; Shimono D; Kuwamura N; Minamikawa J; Nakamura Y
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3452-6. PubMed ID: 11443224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone vs glimepiride and carotid intima-media thickness.
    Kida Y; Sato T
    JAMA; 2007 Mar; 297(12):1316; author reply 1316-7. PubMed ID: 17392237
    [No Abstract]   [Full Text] [Related]  

  • 6. Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria.
    Nakamura T; Ushiyama C; Osada S; Hara M; Shimada N; Koide H
    Metabolism; 2001 Oct; 50(10):1193-6. PubMed ID: 11586492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of pioglitazone on carotid atherosclerosis in Japanese patients with type 2 diabetes without a recent history of macrovascular morbidity.
    Yamasaki Y; Katakami N; Furukado S; Kitagawa K; Nagatsuka K; Kashiwagi A; Daida H; Kawamori R; Kaku K
    J Atheroscler Thromb; 2010 Nov; 17(11):1132-40. PubMed ID: 20686324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pioglitazone vs glimepiride and carotid intima-media thickness.
    Giugliano D; Esposito K
    JAMA; 2007 Mar; 297(12):1315-6; author reply 1316-7. PubMed ID: 17392236
    [No Abstract]   [Full Text] [Related]  

  • 9. Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients.
    Ishimura E; Taniwaki H; Tsuchida T; Obatake N; Emoto M; Shoji T; Shioi A; Inaba M; Nishizawa Y
    J Nephrol; 2007; 20(2):204-11. PubMed ID: 17514625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subclinical atherosclerosis is increased in type 2 diabetic patients with microalbuminuria evaluated by intima-media thickness and pulse wave velocity.
    Yokoyama H; Aoki T; Imahori M; Kuramitsu M
    Kidney Int; 2004 Jul; 66(1):448-54. PubMed ID: 15200455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of pioglitazone with voglibose improves glycemic control safely and rapidly in Japanese type 2-diabetic patients on hemodialysis.
    Abe M; Kikuchi F; Kaizu K; Matsumoto K
    Clin Nephrol; 2007 Nov; 68(5):287-94. PubMed ID: 18044260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of troglitazone on urinary albumin excretion and serum type IV collagen concentrations in Type 2 diabetic patients with microalbuminuria or macroalbuminuria.
    Nakamura T; Ushiyama C; Suzuki S; Shimada N; Sekizuka K; Ebihara L; Koide H
    Diabet Med; 2001 Apr; 18(4):308-13. PubMed ID: 11437862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral ADSORBENT AST-120 decreases carotid intima-media thickness and arterial stiffness in patients with chronic renal failure.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Shimada N; Ebihara I; Koide H
    Kidney Blood Press Res; 2004; 27(2):121-6. PubMed ID: 15051932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial.
    Mazzone T; Meyer PM; Feinstein SB; Davidson MH; Kondos GT; D'Agostino RB; Perez A; Provost JC; Haffner SM
    JAMA; 2006 Dec; 296(21):2572-81. PubMed ID: 17101640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.
    Katakami N; Yamasaki Y; Hayaishi-Okano R; Ohtoshi K; Kaneto H; Matsuhisa M; Kosugi K; Hori M
    Diabetologia; 2004 Nov; 47(11):1906-13. PubMed ID: 15565373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha-Glucosidase inhibitor reduces the progression of carotid intima-media thickness.
    Yamasaki Y; Katakami N; Hayaishi-Okano R; Matsuhisa M; Kajimoto Y; Kosugi K; Hatano M; Hori M
    Diabetes Res Clin Pract; 2005 Mar; 67(3):204-10. PubMed ID: 15713352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow-mediated dilation is associated with microalbuminuria independent of cardiovascular risk factors in type 2 diabetes - interrelations with arterial thickness and stiffness.
    Yokoyama H; Sone H; Saito K; Yamada D; Honjo J; Haneda M
    J Atheroscler Thromb; 2011; 18(9):744-52. PubMed ID: 21597231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different Impacts of Cardiovascular Risk Factors on Arterial Stiffness versus Arterial Wall Thickness in Japanese Patients with Type 2 Diabetes Mellitus.
    Takahara M; Katakami N; Osonoi T; Saitou M; Sakamoto F; Matsuoka TA; Shimomura I
    J Atheroscler Thromb; 2015; 22(9):971-80. PubMed ID: 25864887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between metabolic syndrome components and vascular properties in Japanese type 2 diabetic patients without cardiovascular disease or nephropathy.
    Yokoyama H; Kuramitsu M; Kanno S; Tada J; Yokota Y; Kamikawa F
    Diabetes Res Clin Pract; 2007 Feb; 75(2):200-6. PubMed ID: 16860430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes.
    Matsumura T; Taketa K; Motoshima H; Senokuchi T; Ishii N; Kinoshita H; Fukuda K; Yamada S; Kukidome D; Kondo T; Hisada A; Katoh T; Shimoda S; Nishikawa T; Araki E
    Cardiovasc Diabetol; 2013 Dec; 12():177. PubMed ID: 24373412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.